Stock 300138 CHENGUANG BIOTECH GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights ChenGuang Biotech Group Co., Ltd.

Equities

300138

CNE100000WC5

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 07/05/2024 BST 		5-day change 1st Jan Change
10.09 CNY +1.20% Intraday chart for ChenGuang Biotech Group Co., Ltd. +6.77% -24.87%
04-24 ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-24 ChenGuang Biotech Group Co., Ltd.announces an Increase in Equity Buyback. CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
ChenGuang Biotech Group Co., Ltd.announces an Increase in Equity Buyback.
CI
Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023.
CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
ChenGuang Biotech Group Co., Ltd.announces an Increase in Equity Buyback.
CI
Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023.
CI
ChenGuang Biotech Group Co., Ltd.announces an Increase in Equity Buyback.
CI
ChenGuang Biotech Group Co., Ltd. commences an Equity Buyback Plan for CNY 100 million worth of its shares, under the authorization approved on November 17, 2023.
CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
ChenGuang Biotech Group Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 17 May 2023
CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
ChenGuang Biotech Group Co., Ltd. Approves Cash Dividend for the Year 2022
CI
ChenGuang Biotech Group Co., Ltd. Proposes Final Cash Dividend for the Year 2022
CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Chenguang Biotech Sees 28% Rise in FY'22 Profit
MT
Wang Guangming signed the share transfer agreement to acquire 4.27% stake in Qingdao Spicy Workshop Food Co., Ltd. for 12.40 million.
CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Liu Yingshan signed Equity Transfer Agreement to acquire Xinjiang Tianjiao Hongan Agricultural Technology Co., Ltd. from ChenGuang Biotech Group Co., Ltd. and Xinjiang Chenxi Pepper Industry Co., Ltd. for CNY 88.3 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300138 Stock
  4. News ChenGuang Biotech Group Co., Ltd.
  5. Highlights